Clinical trials
Withdrawn Phase 1/2 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 2 |
| 2023 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Roswell Park Cancer Institute | 2 |
| AstraZeneca | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Centre Leon Berard | 1 |
| City of Hope Medical Center | 1 |
| DelMar Pharmaceuticals, Inc. | 1 |
| Hoosier Cancer Research Network | 1 |
| Immune System Key Ltd | 1 |
| ImmunityBio, Inc. | 1 |
| Imperial College London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 17 |
| Endometrial Neoplasms | 3 |
| Fallopian Tube Neoplasms | 3 |
| Uterine Cervical Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Recurrence | 2 |
| Stomach Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.